Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Chirurgie (Heidelberg, Germany)
|
January 29, 2026
[Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas]
Friederike Eilsberger, Kerstin Michalski, Markus Luster
Nuklearmedizin. Nuclear Medicine
|
November 15, 2019
Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy
Kerstin Michalski, Michael Mix, Philipp T Meyer, et al.
Plos One
|
July 18, 2017
Dealing with foreign cultural paradigms: A systematic review on intercultural challenges of international medical graduates
Kerstin Michalski, Nabeel Farhan, Edith Motschall, et al.
Geburtshilfe Und Frauenheilkunde
|
January 14, 2022
Expression of Prostate Specific Membrane Antigen (PSMA) in Breast Cancer
Clara Unger, Peter Bronsert, Kerstin Michalski, et al.
Clinical Nuclear Medicine
|
May 27, 2022
Diffuse Bone Marrow Involvement of Multiple Myeloma on [ 18 F]PSMA-1007 PET/CT : Is There a Theranostic Potential?
Kerstin Michalski, Cordula A Jilg, Monika Engelhardt, et al.
EJNMMI Research
|
April 11, 2022
Bone marrow impairment during early [<sup>177</sup>Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Felix Kind, Kerstin Michalski, Elham Yousefzadeh-Nowshahr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2021
Assessing Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brueggemann, et al.
Seminars in Nuclear Medicine
|
June 25, 2023
PSMA PET/CT for Response Assessment of <sup>177</sup>Lu-PSMA Therapy
Philipp E Hartrampf, Sebastian E Serfling, Kerstin Michalski, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma
Kerstin Michalski, Wiebke Schlötelburg, Philipp E Hartrampf, et al.
Cancers
|
December 10, 2021
Gastrin-Releasing Peptide Receptor Antagonist [<sup>68</sup>Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer
Kerstin Michalski, Lars Kemna, Jasmin Asberger, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Chirurgie (Heidelberg, Germany)
|
January 29, 2026
[Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas]
Friederike Eilsberger, Kerstin Michalski, Markus Luster
Nuklearmedizin. Nuclear Medicine
|
November 15, 2019
Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy
Kerstin Michalski, Michael Mix, Philipp T Meyer, et al.
Plos One
|
July 18, 2017
Dealing with foreign cultural paradigms: A systematic review on intercultural challenges of international medical graduates
Kerstin Michalski, Nabeel Farhan, Edith Motschall, et al.
Geburtshilfe Und Frauenheilkunde
|
January 14, 2022
Expression of Prostate Specific Membrane Antigen (PSMA) in Breast Cancer
Clara Unger, Peter Bronsert, Kerstin Michalski, et al.
Clinical Nuclear Medicine
|
May 27, 2022
Diffuse Bone Marrow Involvement of Multiple Myeloma on [ 18 F]PSMA-1007 PET/CT : Is There a Theranostic Potential?
Kerstin Michalski, Cordula A Jilg, Monika Engelhardt, et al.
EJNMMI Research
|
April 11, 2022
Bone marrow impairment during early [<sup>177</sup>Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Felix Kind, Kerstin Michalski, Elham Yousefzadeh-Nowshahr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2021
Assessing Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brueggemann, et al.
Seminars in Nuclear Medicine
|
June 25, 2023
PSMA PET/CT for Response Assessment of <sup>177</sup>Lu-PSMA Therapy
Philipp E Hartrampf, Sebastian E Serfling, Kerstin Michalski, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma
Kerstin Michalski, Wiebke Schlötelburg, Philipp E Hartrampf, et al.
Cancers
|
December 10, 2021
Gastrin-Releasing Peptide Receptor Antagonist [<sup>68</sup>Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer
Kerstin Michalski, Lars Kemna, Jasmin Asberger, et al.
Page
of 4